Shirley’s “so well” on her latest treatment – daratumumab
Shirley Irwin has had radiotherapy and two transplants, had surgery, five different lines of treatment, and relapsed twice.
- Myeloma
- Treatments and side-effects
Shirley Irwin has had radiotherapy and two transplants, had surgery, five different lines of treatment, and relapsed twice.
Jack was 22 years old when he was diagnosed with a dangerous blood disorder called aplastic anaemia.
Dr Bruce Levine explains how it works and why.
Cancer-related fatigue is a side-effect that has an enormous impact on quality of life.
Dr Khai Li Chai is working to improve the prevention and treatment of infection in blood cancer patients with antibody replacement therapy.
There’s an urgent need for new approaches to better prevent and treat GVHD.
Bruce was the first patient in Adelaide to join an international CLL trial.
Acalabrutinib (Calquence®) will be added to the therapy arsenal for CLL and SLL.
The Pharmaceutical Benefits Advisory Committee (PBAC) considered four blood cancer treatments at its March 2020 meeting including a drug for myeloma – plitidepsin (Aplidin®).
More than 600 Australians have a potentially life-saving stem cell transplant each year.